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Peroxisomes are a major cellular compartment of eukaryotic cells, and are
involved in a variety of metabolic functions and pathways according to species,
cell type and environmental conditions. Their biogenesis relies on conserved
genes known as PEX genes that encode peroxin proteins. Peroxisomal
membrane proteins and peroxisomal matrix proteins are generated in the
cytosol and are subsequently imported into the peroxisome post-translationally.
Matrix proteins containing a peroxisomal targeting signal type 1 (PTS1) are
recognized by the cycling receptor Pex5p and transported to the peroxisomal
lumen. Pex5p docking, release of the cargo into the lumen and recycling involve
a number of peroxins, but a key player is the Pex4p–Pex22p complex described
in this manuscript. Pex4p from the yeast Saccharomyces cerevisiae is a ubiquitin-
conjugating enzyme that is anchored on the cytosolic side of the peroxisomal
membrane through its binding partner Pex22p, which acts as both a docking site
and a co-activator of Pex4p. As Pex5p undergoes recycling and release, the
Pex4p–Pex22p complex is essential for monoubiquitination at the conserved
cysteine residue of Pex5p. The absence of Pex4p–Pex22p inhibits Pex5p
recycling and hence PTS1 protein import. This article reports the crystallization
of Pex4p and of the Pex4p–Pex22p complex from the yeast Hansenula
polymorpha, and data collection from their crystals to 2.0 and 2.85 A˚ resolution,
respectively. The resulting structures are likely to provide important insights to
understand the molecular mechanism of the Pex4p–Pex22p complex and its role
in peroxisome biogenesis.
1. Introduction
Peroxisomes are organelles that are involved in many meta-
bolic functions and pathways, depending upon the species, cell
type and environmental conditions. Such functions include the
oxidation of fatty acids, the protection of cells from oxidative
damage (Fujiki et al., 2012; Wanders & Waterham, 2006), the
metabolism of specific carbon and/or nitrogen sources, for
example methanol, d-alanine, primary amines or oleic acid, in
yeasts (Klei & Veenhuis, 1996), and the synthesis of plasma-
logens, cholesterol and bile acids in mammals (van den Bosch
et al., 1992). Their biogenesis relies on highly conserved genes
known as PEX genes that encode peroxins, which mainly
function in the formation of peroxisomes or the import of
matrix and membrane proteins (Fujiki et al., 2012; Titorenko
& Rachubinski, 2001). For example, Pex5p is a key cytosolic
recycling receptor for matrix proteins imported through the
peroxisomal targeting signal type 1 (PTS1) pathway (Williams
& Stanley, 2010). The Pex5p import cycle can be divided into
the following steps: (i) recognition of a PTS1-containing
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protein by Pex5p in the cytosol (Gatto et al., 2000; Stanley et
al., 2006), (ii) docking of the Pex5p–cargo complex at the
peroxisomal membrane (Elgersma et al., 1996; Albertini et al.,
1997), (iii) cargo translocation into the peroxisomal lumen
(Meinecke et al., 2010; Wang et al., 2003) and (iv) recycling of
Pex5p for a new import cycle (Platta et al., 2007, 2008).
Although the recycling of the Pex5p receptor has been studied
in detail, the mechanism of cargo release remains elusive (Kim
& Hettema, 2015; Girzalsky et al., 2010).
The receptor-recycling step involves monoubiquitination of
Pex5p at the conserved cysteine residue (Williams et al., 2007;
Okumoto et al., 2011) and requires the action of a number of
peroxins, including Pex1p, Pex4p, Pex6p, Pex15p and Pex22p
(Koller et al., 1999; Collins et al., 2000; Platta et al., 2008;
Rosenkranz et al., 2006). Several studies have shown that the
ubiquitin-conjugating (E2) enzyme Pex4p is responsible for
Pex5p monoubiquitination in the yeast Saccharomyces cere-
visiae (El Magraoui et al., 2014; Williams et al., 2007; Platta et
al., 2007). Pex4p associates with the peroxisomal membrane
via its interaction with the membrane-bound Pex22p (Koller et
al., 1999). However, Pex22p also acts as a co-activator of
Pex4p, stimulating the E2 activity of Pex4p through an
unknown mechanism (Williams et al., 2012, 2013; El Magraoui
et al., 2014).
In order to understand the molecular mechanism guiding
the assembly of the Pex4p–Pex22p complex, as well as the role
of Pex22p as a co-activator protein, further high-resolution
structural models of the partners in the complex are required.
Here, we report the crystallization of Pex4p alone and in
complex with the soluble domain of Pex22p (hereafter
referred to as Pex22S) from the yeast Hansenula polymorpha.
Moreover, we used microscale thermophoresis to analyse the
dissociation constant (Kd) of the Pex4p–Pex22
S complex in
vitro.
2. Materials and methods
2.1. Cloning of Pex4p and Pex22S
Escherichia coli plasmids for the expression of His6-GST-
tagged wild-type Pex4p and the soluble region of Pex22p
(Pex22S; residues 26–160) were made as follows: PCR was
performed on H. polymorpha genomic DNA using the primer
combinations HpP4 NcoI (GCCATGGCTTCTACAGAAA
AGCGG) and HpP4 HindIII (GCGAAGCTTTATACAT
CATTAGATTCGTATGC) for Pex4p and HpP22 NcoI
(CCATGGCCTGGGCGTTGAAGACG) and HpP22 HindIII
(GCGAAGCTTTATATATAATCATTTATACGATCC) for
Pex22S; the resulting fragments were digested with NcoI and
HindIII and ligated into NcoI–HindIII-digested pETM-30
vector. For cloning details, please refer to Table 1.
2.2. Expression and purification of Pex4p and Pex22S
E. coli BL21 (DE3) RIL competent cells were transformed
with either the pETM-30-Pex4p or the pETM-30-Pex22S
expression plasmid. These plasmids encode wild-type Pex4p
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Table 1
Macromolecule-production information for Pex22S and Pex4p.
Cloning details for Pex22S and Pex4p from H. polymorpha. Restriction sites in the primers for the wild type are shown in bold. Additional residues at the
N-terminus are underlined. The beginning and end numbers of the amino-acid sequences are shown as subscripts.
Pex22S Pex4p
Source organism H. polymorpha H. polymorpha
DNA source H. polymorpha genomic DNA H. polymorpha genomic DNA
Forward primer (NcoI) 50-CCATGGCCTGGGCGTTGAAGACG-30 50-GCCATGGCTTCTACAGAAAAGCGG-30
Reverse primer (HindIII) 50-GCGAAGCTTTATATATAATCATTTATACGATCC-30 50-GCGAAGCTTTATACATCATTAGATTCGTATGC-30
Expression vector pETM-30 pETM-30
Expression host E. coli E. coli
Complete amino-acid sequence










† After TEV digestion.
Table 2
Crystallization of Pex4p and of the Pex4p–Pex22S complex, including the final buffer compositions and the conditions in which crystals were grown.
Pex4p Pex4p–Pex22S complex
Method Hanging-drop vapour diffusion Sitting-drop vapour diffusion
Plate type 24-well XRL Plate (Molecular Dimensions,
catalogue No. MD11-00-100)
96-well Polystyrene MRC Crystallization Plate
(Molecular Dimensions, catalogue No. MD3-11)
Temperature (K) 293 293
Protein concentration (mg ml1) 12 12
Buffer composition of protein solution 25 mM Tris, 150 mM NaCl, 1% glycerol,
1 mM BME pH 7.5
25 mM Tris, 150 mM NaCl, 1% glycerol,
1 mM BME pH 7.5
Buffer composition of reservoir solution 0.1 M MES, 50%(v/v) PEG 200 pH 6.5 0.1 M bis-tris propane, 0.2 M sodium sulfate,
22%(w/v) PEG 3350 pH 7.8
Volume and ratio of the drops 2 ml (1:1 ratio) 320 nl (1:1 ratio)
and the soluble region of Pex22p, respectively, both fused to a
N-terminal GST and His6 tag. Expression of both constructs
was performed according to the following protocol. The
transformed colonies were selected on LB agar plates
supplemented with kanamycin (25 mg ml1) and chloram-
phenicol (35 mg ml1). A single colony was used to inoculate a
10 ml culture of LB supplemented with kanamycin
(25 mg ml1) and chloramphenicol (35 mg ml1), which was
then incubated in a shaking incubator at 310 K for 4–5 h. The
culture was then used to inoculate 1 l TB supplemented with
kanamycin (25 mg ml1) and chloramphenicol (25 mg ml1)
and allowed to grow at 310 K to an OD600 of 0.8. The cells
were then cooled to 294 K and induced with isopropyl -d-1-
thiogalactopyranoside at a final concentration of 50 mM. Both
cultures were further incubated at 294 K for 18 h. After
harvesting, the cell pellets were resuspended in buffer 1
[50 mM Tris, 300 mM NaCl, 1 mM -mercaptoethanol (BME)
pH 7.5] and lysed using a French press. The lysate was then
clarified by centrifugation (18 000 rev min1; SS-34 rotor,
Sorvall) before incubation with 5 ml glutathione S-transferase
(GST) resin (GE Healthcare). The resin was further sequen-
tially washed in buffer 1, buffer 2 (50 mM Tris, 1 M NaCl, 1%
glycerol, 1 mM BME pH 7.5) and buffer 3 (50 mM Tris,
150 mM NaCl, 1% glycerol, 1 mM BME pH 7.5). The target
proteins were eluted with 20–30 ml elution buffer (buffer 3
supplemented with 20 mM reduced glutathione). Subse-
quently, the eluted Pex4p and Pex22S proteins were subjected
to TEV cleavage (using a ratio of 1 mg TEV to 25 mg fusion
protein) overnight at 277 K without shaking. Both TEV and
the N-terminal cleavage products containing the His6 tag were
removed by passage through Ni–NTA agarose and the flow-
through was collected. Pure Pex4p and Pex22S were present in
the flowthrough, which was concentrated using centrifugal
concentrators (10 000 Da molecular-weight cutoff; Vivaspin
20, Sartorius). The proteins were further purified by size-
exclusion chromatography (SEC) using a Superdex 75 16/60
column (GE Healthcare) equilibrated with GF buffer (25 mM
Tris, 150 mM NaCl, 1% glycerol, 1 mM BME pH 7.4). The
Pex4p–Pex22S complex was prepared by incubating a mixture
of Pex4p and Pex22S [at a 1:1.8 molar ratio as determined
using UV spectroscopy and their tabulated extinction coeffi-
cients (https://www.expasy.org)] for 1 h on ice. The sample was
further concentrated prior to injection onto an SEC column
(Superdex 75 16/60; GE Healthcare) previously equilibrated
with GF buffer.
2.3. Crystallization of Pex4p and the Pex4p–Pex22S complex
Purified Pex4p was concentrated using a Vivaspin 20
concentrator (Sartorius) to 12 mg ml1 for crystallization
trials. Pex4p crystallization conditions were established using
the high-throughput crystallization platform at the EMBL
(Hamburg) and initial crystals were identified in 0.1 M MES,
40%(v/v) PEG 200 pH 6.5. Further optimization of the crys-
tallization conditions resulted in high-quality crystals that
were appropriate for X-ray diffraction analysis, which were
obtained in 0.1 M MES, 50%(v/v) PEG 200 pH 6.5 from plates
that were incubated at 293 K. Similarly, the Pex4p–Pex22S
complex was concentrated to 12 mg ml1 and was used for
crystallization trials using a Mosquito high-throughput crys-
tallization robot (TTP Labtech). The concentration was
calculated based on an assumed 1:1 complex and the respec-
tive tabulated extinction coefficients (https://www.expasy.org).
Initial screening was carried out with two screening kits: PACT
premier HT-96 and JCSG-plus (Molecular Dimensions). The
plates were incubated at 293 K for a week and initial crystals
were identified in 0.1 M bis-tris propane, 0.2 M sodium sulfate,
20%(w/v) PEG 3350 pH 7.5. After optimization of the crys-
tallization buffer to 0.1 M bis-tris propane, 0.2 M sodium
sulfate, 22%(w/v) PEG 3350 pH 7.8, a single crystal that was
suitable for X-ray diffraction analysis was obtained. Table 2
summarizes the crystallization conditions. Several crystals of
the complex were grown during optimization of the condi-
tions, with fine needle shapes in a fan-like structure. These
crystals were fragile and were difficult to fish out prior to
diffraction studies. Seeding was not attempted.
Crystals of Pex4p as well as those of the Pex4p–Pex22S
complex were transferred to a cryobuffer consisting of the
reservoir buffer supplemented with 20%(v/v) glycerol and
were then flash-cooled in liquid nitrogen prior to data
collection. The crystals were shipped using a dry-shipping
container (Taylor–Wharton) to the PETRA III synchrotron,
Hamburg, Germany for diffraction data collection.
2.4. Microscale thermophoresis (MST)
MST measurements were performed on a Nanotemper
Monolith NT.115 instrument (Nanotemper Technologies
GmbH). Purified Pex4p was labelled with the Monolith
Protein Labelling Kit RED according to the supplied protocol
(Nanotemper Technologies GmbH). The labelled protein was
concentrated using a PES centrifugation filter (3 kDa cutoff;
VWR), diluted with glycerol [final concentration of 50%(v/v)]
and the aliquots were stored at 193 K. Measurements were
performed in MST buffer (25 mM Tris pH 7.5, 125 mM NaCl,
1% glycerol, 1 mM BME, 0.05% Tween 20) in standard
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Figure 1
Needle-shaped Pex4p crystals produced in 0.1 M MES, 50%(v/v) PEG
200 pH 6.5.
capillaries (K002; Nanotemper Technologies GmbH).
Labelled Pex4p was used at a final concentration of 10 nM.
Pex22s was titrated in 1:1 dilutions starting at 2.82 mM. All
binding reactions were incubated for 10 min at room
temperature followed by centrifugation at 20 000g before
loading into capillaries. All measurements were performed in
triplicate at 20% LED and 60% MST power; the laser on time
was 30 s and the laser off time was 5 s.
3. Results
3.1. Crystallization of Pex4p
Full-length Pex4p protein was purified from an E. coli-
based expression system and the purified protein was crys-
tallized at 293 K (Fig. 1). The final crystals were grown in
0.1 M MES, 50%(v/v) PEG 200 pH 6.5. A single crystal was
harvested in a mounted loop, directly flash-cooled in liquid
nitrogen and transported to the P11 beamline at PETRA III,
Hamburg for data collection and structural analysis.
3.2. Crystallization of the Pex4p–Pex22S complex
An initial crystal of the Pex4p–Pex22S complex was grown
in a solution consisting of 0.1 M bis-tris propane, 0.2 M sodium
sulfate, 20%(w/v) PEG 3350 pH 7.5 from the PACT premier
HT-96 screening kit (Molecular Dimensions) as shown in
Fig. 2(a). Fig. 2(b) illustrates the final crystal, which was grown
in 0.1 M bis-tris propane, 0.2 M sodium sulfate, 22%(w/v)
PEG 3350 pH 7.8. The crystal was directly harvested and flash-
cooled for data collection and structural analysis as indicated
above.
3.3. Data collection and processing
The Pex4p crystal used for the experiment diffracted to a
resolution of 2.0 A˚ and X-ray data were collected on beamline
P11 at the PETRA III synchrotron, DESY, Germany. The raw
data were processed automatically, using the XDS software
(Kabsch, 2010) for integration and truncation of the data. The
Pex4p crystal belonged to space group P41212, with unit-cell
parameters a = 46.35, b = 46.35, c = 206.41 A˚,  =  =  = 90.
Similarly, diffraction data from the Pex4p–Pex22S complex
crystal were also collected on beamline P11 at the PETRA III
synchrotron, DESY, Germany. The crystal diffracted to a
maximal resolution of 2.85 A˚. The crystal of the complex
belonged to space group P1, with unit-cell parameters a = 44.7,
b = 61.6, c = 78.4 A˚,  = 89.2,  = 78.0,  = 84.1. The raw data
were processed automatically using XDS (Kabsch, 2010).
Data-collection and processing statistics are summarized in
Table 3.
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Table 3
Data-collection statistics.




X-ray source PETRA III PETRA III
Beamline P11 P11
Wavelength (A˚) 1.03 0.98
Space group P41212 P1
a, b, c (A˚) 46.35, 46.35, 206.41 44.7, 61.6, 78.4
, ,  () 90, 90, 90 89.2, 78.0, 84.1
Resolution (A˚) 45.22–2.00 (2.26–2.00) 76.7–2.85 (2.95–2.85)
Rmeas† 0.147 (0.74) 0.123 (0.80)
Total No. of observations 59646 (1977) 71456 (9995)
Total No. of unique reflections 14409 (1206) 18181 (1822)
Mean I/(I) 6.21 (1.69) 6.03 (1.14)
Completeness (%) 92 (88) 95.02 (94.5)
Wilson B factor (A˚2) 42.5 48.9
Multiplicity 4.1 (1.6) 3.9 (5.48)
CC1/2 0.995 (0.426) 0.996 (0.529)
Matthews coefficient (A˚3 Da1) 2.63 2.92
Mosaicity () 0.13 0.42




i jIiðhklÞ  hIðhklÞij=P
hkl
P
i IiðhklÞ, where Ii(hkl) is the ith intensity measurement of reflection hkl and
hI(hkl)i is the average intensity from multiple observations.
Figure 2
(a) Initial crystals grown in 0.1 M bis-tris propane, 0.2 M ammonium sulfate, 20%(w/v) PEG 3350 pH 7.5 (PACT premier HT-96, Molecular Dimensions).
The drops were set up by the sitting-drop method with a Mosquito robot (TTP Labtech) using drops consisting of 160 nl protein solution and 160 nl
precipitant solution, and the plates were incubated at 293 K. (b) The final crystals grown in 0.1 M bis-tris propane, 0.2 M ammonium sulfate, 22%(w/v)
PEG 3350 pH 7.8. The drops were set up by the sitting-drop method with a Mosquito robot (TTP Labtech) using drops consisting of 160 nl protein
solution and 160 nl precipitant solution, and the plates were incubated at 293 K.
The structure of Pex4p was solved with the MOLREP
molecular-replacement software using the structure of
S. cerevisiae Pex4p as a search model (PDB entry 2y9m; 31%
identity and 66% similarity; Williams et al., 2012); the solution
had a Z-score of 10.0. The coordinates of the Pex4p–Pex22S
complex from S. cerevisiae (PDB entry 2y9m; 31% identity
and 66% similarity for Pex4p and 15% identity and 48%
similarity for Pex22S) were also used as a search model to
interpret the Pex4p–Pex22S data from H. polymorpha,
yielding a molecular-replacement solution (Z-score of 12.4)
with two copies of each partner in the protein complex
(Pex4p–Pex22S).
3.4. Pex4p–Pex22S binding
Parameters for Pex4p–Pex22S complex formation were
assessed using microscale thermophoresis (MST). MST relies
on the motion of molecules in microscopic temperature
gradients to detect minute changes in the charge, size and
hydration shell of a molecule (Jerabek-Willemsen et al., 2011;
Wienken et al., 2010). In this experiment, fluorescently
labelled Pex4p, previously purified to homogeneity (see x2),
was titrated with Pex22S. Fig. 3 shows an MST curve for Pex4p
in the presence of different concentrations of Pex22S. The
dissociation constant for the Pex4p–Pex22S interaction was
calculated to be 1.94  0.39 nM. This is in good agreement
with the reported binding affinity between Pex4p and Pex22S
from S. cerevisiae as determined by isothermal titration
calorimetry (ITC): 2.00  0.08 nM (Williams et al., 2012).
4. Discussion
The structure of H. polymorpha Pex4p was solved by mole-
cular replacement using the Pex4p structure from S. cerevisiae
as a search model (PDB entry 2y9m; 31% identity and 66%
similarity to H. polymorpha Pex4p). The structure of the
H. polymorpha Pex4p–Pex22S complex was solved using a
model built from the structure of H. polymorpha Pex4p
together with that of S. cerevisiae Pex22S from the S. cerevisiae
Pex4p–Pex22S structure (PDB entry 2y9m; 15% identity and
48% similarity to H. polymorpha Pex22S), yielding a clear
molecular-replacement solution with two copies of H. poly-
morpha Pex4p–Pex22S. Our structural analysis of H. poly-
morpha Pex4p and the Pex4p–Pex22S protein complex will be
reported elsewhere (manuscript in preparation).
Pex22p acts as a co-activator of Pex4p, stimulating the
activity of the E2 enzyme through an as yet unknown
mechanism (Williams et al., 2012, 2013; El Magraoui et al.,
2014). Hence, we anticipate that the structures resulting from
the data reported here will provide important insights into the
molecular mechanism underlying the Pex22p-dependent co-
activation of Pex4p and how this impacts on the role of Pex4p
in peroxisome biogenesis.
The use of MST allowed more precise insight into complex
formation. The low-nanomolar dissociation constant for
complex formation in vitro (1.94  0.39 nM) suggests that
tight binding is required for the activation of Pex4p. A 1:1
stoichiometry for the binding is also supported by our MST
data (Fig. 3), as at a 1:1 ratio (10 nM:10 nM) the curve is close
to saturation. Our MST data are in agreement with previous
ITC data provided for the Pex4p–Pex22S complex from
S. cerevisiae, in that the dissociation constant (Kd) is equal to
2.0  0.08 nM (Williams et al., 2012). It should be borne in
mind that these two affinity measurements of the Pex4p–
Pex22S interaction, while in good agreement, are from distinct
species. As a result, a direct comparison of the methods is
difficult to defend, although the MST sample requirements are
significantly lower.
Acknowledgements
The authors would like to thank the staff of the P11 beamline
at the PETRA III synchrotron, DESY, Hamburg for beamline
access. The authors would also like to thank Dr Christian
Kleusch and Dr Katarzyna Walkiewicz from Nanotemper
Technologies GmbH for technical support and advice.
Funding information
CW is supported by a VIDI Grant (723.013.004) from the
Netherlands Organization for Scientific Research (NWO).
AMA gratefully acknowledges the Qatar Research Leader-
ship (QRLP)–Qatar Foundation for financial support.
References
Albertini, M., Rehling, P., Erdmann, R., Girzalsky, W., Kiel, J. A.,
Veenhuis, M. & Kunau, W. H. (1997). Cell, 89, 83–92.
Bosch, H. van den, Schutgens, R. B. H., Wanders, R. J. A. & Tager,
J. M. (1992). Annu. Rev. Biochem. 61, 157–197.
Collins, C. S., Kalish, J. E., Morrell, J. C., McCaffery, J. M. & Gould,
S. J. (2000). Mol. Cell. Biol. 20, 7516–7526.
Elgersma, Y., Kwast, L., Klein, A., Voorn-Brouwer, T., van den Berg,
M., Metzig, B., America, T., Tabak, H. F. & Distel, B. (1996). J. Cell
Biol. 135, 97–109.
research communications
80 Ali et al.  Pex4p–Pex22p complex Acta Cryst. (2018). F74, 76–81
Figure 3
MST curve for the binding of Pex4p to Pex22S, displaying 1:1
stoichiometry. The assay was performed using a fixed concentration of
fluorescently labelled Pex4p (10 nM).
El Magraoui, F., Schro¨tter, A., Brinkmeier, R., Kunst, L., Mastalski,
T., Mu¨ller, T., Marcus, K., Meyer, H. E., Girzalsky, W., Erdmann, R.
& Platta, H. W. (2014). PLoS One, 9, e105894.
Fujiki, Y., Yagita, Y. & Matsuzaki, T. (2012). Biochim. Biophys. Acta,
1822, 1337–1342.
Gatto, G. J. Jr, Geisbrecht, B. V., Gould, S. J. & Berg, J. M. (2000).
Nature Struct. Biol. 7, 1091–1095.
Girzalsky, W., Saffian, D. & Erdmann, R. (2010). Biochim. Biophys.
Acta, 1803, 724–731.
Jerabek-Willemsen, M., Wienken, C. J., Braun, D., Baaske, P. & Duhr,
S. (2011). Assay Drug Dev. Technol. 9, 342–353.
Kabsch, W. (2010). Acta Cryst. D66, 125–132.
Kim, P. K. & Hettema, E. H. (2015). J. Mol. Biol. 427, 1176–1190.
Klei, I. J. van der & Veenhuis, M. (1996). Ann. N. Y. Acad. Sci. 804,
47–59.
Koller, A., Snyder, W. B., Faber, K. N., Wenzel, T. J., Rangell, L.,
Keller, G. A. & Subramani, S. (1999). J. Cell Biol. 146, 99–112.
Meinecke, M., Cizmowski, C., Schliebs, W., Kru¨ger, V., Beck, S.,
Wagner, R. & Erdmann, R. (2010). Nature Cell Biol. 12, 273–277.
Okumoto, K., Misono, S., Miyata, N., Matsumoto, Y., Mukai, S. &
Fujiki, Y. (2011). Traffic, 12, 1067–1083.
Platta, H. W., Debelyy, M. O., El Magraoui, F. & Erdmann, R. (2008).
Biochem. Soc. Trans. 36, 99–104.
Platta, H. W., El Magraoui, F., Schlee, D., Grunau, S., Girzalsky, W. &
Erdmann, R. (2007). J. Cell Biol. 177, 197–204.
Rosenkranz, K., Birschmann, I., Grunau, S., Girzalsky, W., Kunau,
W. H. & Erdmann, R. (2006). FEBS J. 273, 3804–3815.
Stanley, W. A., Filipp, F. V., Kursula, P., Schu¨ller, N., Erdmann, R.,
Schliebs, W., Sattler, M. & Wilmanns, M. (2006). Mol. Cell, 24, 653–
663.
Titorenko, V. I. & Rachubinski, R. A. (2001). Trends Cell Biol. 11, 22–
29.
Wanders, R. J. A. & Waterham, H. R. (2006). Annu. Rev. Biochem. 75,
295–332.
Wang, D., Visser, N. V., Veenhuis, M. & van der Klei, I. J. (2003). J.
Biol. Chem. 278, 43340–43345.
Wienken, C. J., Baaske, P., Rothbauer, U., Braun, D. & Duhr, S.
(2010). Nature Commun. 1, 100.
Williams, C., van den Berg, M., Panjikar, S., Stanley, W., Distel, B. &
Wilmanns, M. (2012). EMBO J. 31, 391–402.
Williams, C., van den Berg, M., Sprenger, R. R. & Distel, B. (2007). J.
Biol. Chem. 282, 22534–22543.
Williams, C., van den Berg, M., Stanley, W. A., Wilmanns, M. & Distel,
B. (2013). Sci. Rep. 3, 2212.
Williams, C. P. & Stanley, W. A. (2010). Int. J. Biochem. Cell Biol. 42,
1771–1774.
research communications
Acta Cryst. (2018). F74, 76–81 Ali et al.  Pex4p–Pex22p complex 81
